Opportunities and challenges of endoscopic sleeve gastroplasty.
10.12122/j.issn.1673-4254.2020.06.22
- Author:
Liangping WU
1
;
Xiaojiang DAI
1
;
Hongyan HUANG
1
Author Information
1. Surgical Center for Obesity and Diabetes, Jinshazhou Hospital, Guangzhou University of Chinese Medicine, Guangzhou 510000, China.
- Publication Type:Journal Article
- Keywords:
bariatric surgery;
endoscopic sleeve gastroplasty;
obesity
- MeSH:
Diabetes Mellitus, Type 2;
Gastrectomy;
Gastroplasty;
Humans;
Laparoscopy;
Obesity, Morbid;
Treatment Outcome;
Weight Loss
- From:
Journal of Southern Medical University
2020;40(6):916-918
- CountryChina
- Language:Chinese
-
Abstract:
Obesity and its complications, such as type 2 diabetes, hypertension, hyperlipidemia, nonalcoholic fatty liver, are serious global public health problems. Endoscopic sleeve gastroplasty (ESG) can reduce the length and width of the stomach by simulating the anatomical structure of surgical sleeve gastrectomy to reduce the capacity of the stomach, and is safe and effective to reduce weight. ESG has the advantages of non- invasiveness, no gastrectomy, repeatability, simple operation, no incision scar, few complications, short hospital stay and quick postoperative recovery. As an intermediate means of medical treatment and surgery, ESG provides a new method for weight loss for obese patients who cannot tolerate or are unwilling to undergo surgery. Herein we trace the origin of ESG, analyze the unique advantages of ESG suture, explore the technical improvement in the development of ESG, and briefly describe the weight reduction effect of ESG and compare the curative effect of ESG with laparoscopic sleeve gastrectomy. ESG has undergone rapid development and maturity but also faces such challenges as the lack of established standard procedures, unclear weight reduction mechanism, and clarification of the indications for operation. Still, ESG is expected to become the mainstream technique for weight reduction.
